glp-1 agonists: What do GLP 1 receptor agonists actually do GLP-1R and Diabetes

Greger cuts through the promotional puffery and presents the pros and cons of these weight-loss drugs so individuals can make up their own mind in the face of the very real and devastating consequences of obesity

Afternoon fatigue and brain fog

Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and drug-related deaths.

Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are two gut hormones, defined incretins, responsible for the amplification of insulin secretion after oral glucose intake